Shopping Cart 0
Cart Subtotal
AED 0

OWC Pharmaceutical Research Corp (OWCP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

OWC Pharmaceutical Research Corp (OWC Pharmaceutical), formerly Dynamic Applications Corp, is a drug development company that discovers, develops, and commercializes cannabis-based novel therapeutics products and treatments for several medical conditions. The company offers sublingual soluble tablets and topical cream. Its sublingual soluble tablets provide patients with an alternative to smoking cannabis (marijuana) buds for the treatment and management of pain. OWC Pharmaceutical's topical cream is used for the treatment of various skin diseases. The company's products are also used for the treatment of multiple myeloma, psoriasis, fibromyalgia, post-traumatic stress disorder, and migraines. It offers medical cannabis regulatory compliance and patient-care consultancy services. The company operates through its subsidiary in Israel. OWC Pharmaceutical is headquartered in Ramat Gan, Israel.

OWC Pharmaceutical Research Corp (OWCP)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

OWC Pharmaceutical Research Corp, Medical Devices Deals, 2012 to YTD 2018 9

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deal Details 11

Private Equity 11

Kodiak Capital Group to Invest USD0.7 Million in OWC Pharma 11

Partnerships 12

OWC Pharmaceutical Research Entered into a License Agreement with Emilia Cosmetics 12

One World Cannabis Enters into Agreement with G.C. Group 13

One World Cannabis Signs Collaboration Agreement with Sheba Academic Medical Center 14

OWC Pharmaceutical Research Enters into Agreement with Sheba Academic Medical Center 15

OWC Pharmaceutical Research Enters into Agreement with GUMI Tel Aviv 16

Licensing Agreements 17

OWC Pharmaceutical Enters into License Agreement with Sheba Academic Medical for Fibromyalgia 17

OWC Pharmaceutical Enters into License Agreement with Sheba Academic Medical for Psoriasis 18

Equity Offering 19

OWC Pharma Raises USD5 Million in Private Placement of Shares 19

OWC Pharma to Raise USD0.3 Million in Private Placement of Shares 20

OWC Pharma Raises USD0.02 Million in Priavte Placement of Shares 21

OWC Pharmaceutical Raises USD0.65 Million in Priavte Placement of Shares 22

OWC Pharmaceutical Research Raises USD1.1 Million in Private Placement of Units 23

OWC Pharmaceutical Research Raises USD0.9 Million in Priavte Placement of Units 24

OWC Pharmaceutical Research Corp-Key Competitors 25

OWC Pharmaceutical Research Corp-Key Employees 26

OWC Pharmaceutical Research Corp-Locations And Subsidiaries 27

Head Office 27

Other Locations & Subsidiaries 27

Recent Developments 28

Corporate Communications 28

Feb 20, 2018: OWC Pharmaceutical Research Appoints Dr. Oron Yacoby Zeevi as its Chief Scientific Officer 28

Jul 25, 2017: OWC Pharmaceutical Research Corp Appoints Dr. Stanley Hirsch as its Active Chairman 29

Jan 27, 2017: OWC Pharmaceutical Research Announces the Nominations of Ms. Miriam Sani, MSc Eng., to its Advisory Board 30

Product News 31

Dec 21, 2017: OWC Pharmaceutical Research Announces Update on its Proprietary Medical Cannabis Sublingual Tablet 31

Other Significant Developments 32

Jul 24, 2018: OWC Pharmaceutical Research letter to shareholders 32

Appendix 33

Methodology 33

About GlobalData 33

Contact Us 33

Disclaimer 33


List Of Figure

List of Figures

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

OWC Pharmaceutical Research Corp, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

OWC Pharmaceutical Research Corp, Deals By Therapy Area, 2012 to YTD 2018 8

OWC Pharmaceutical Research Corp, Medical Devices Deals, 2012 to YTD 2018 9

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Kodiak Capital Group to Invest USD0.7 Million in OWC Pharma 11

OWC Pharmaceutical Research Entered into a License Agreement with Emilia Cosmetics 12

One World Cannabis Enters into Agreement with G.C. Group 13

One World Cannabis Signs Collaboration Agreement with Sheba Academic Medical Center 14

OWC Pharmaceutical Research Enters into Agreement with Sheba Academic Medical Center 15

OWC Pharmaceutical Research Enters into Agreement with GUMI Tel Aviv 16

OWC Pharmaceutical Enters into License Agreement with Sheba Academic Medical for Fibromyalgia 17

OWC Pharmaceutical Enters into License Agreement with Sheba Academic Medical for Psoriasis 18

OWC Pharma Raises USD5 Million in Private Placement of Shares 19

OWC Pharma to Raise USD0.3 Million in Private Placement of Shares 20

OWC Pharma Raises USD0.02 Million in Priavte Placement of Shares 21

OWC Pharmaceutical Raises USD0.65 Million in Priavte Placement of Shares 22

OWC Pharmaceutical Research Raises USD1.1 Million in Private Placement of Units 23

OWC Pharmaceutical Research Raises USD0.9 Million in Priavte Placement of Units 24

OWC Pharmaceutical Research Corp, Key Competitors 25

OWC Pharmaceutical Research Corp, Key Employees 26

OWC Pharmaceutical Research Corp, Subsidiaries 27

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

OWC Pharmaceutical Research Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

OWC Pharmaceutical Research Corp (OWC Pharmaceutical), formerly Dynamic Applications Corp, is a drug development company that discovers, develops, and commercializes cannabis-based novel therapeutics products and treatments for several medical conditions. The company offers sublingual soluble tablets and topical cream. Its sublingual soluble tablets provide patients with an alternative to smoking cannabis (marijuana) buds for the treatment and management of pain. OWC Pharmaceutical's topical cream is used for the treatment of various skin diseases. The company's products are also used for the treatment of multiple myeloma, psoriasis, fibromyalgia, post-traumatic stress disorder, and migraines. It offers medical cannabis regulatory compliance and patient-care consultancy services. The company operates through its subsidiary in Israel. OWC Pharmaceutical is headquartered in Ramat Gan, Israel.

OWC Pharmaceutical Research Corp (OWCP)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

OWC Pharmaceutical Research Corp, Medical Devices Deals, 2012 to YTD 2018 9

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deal Details 11

Private Equity 11

Kodiak Capital Group to Invest USD0.7 Million in OWC Pharma 11

Partnerships 12

OWC Pharmaceutical Research Entered into a License Agreement with Emilia Cosmetics 12

One World Cannabis Enters into Agreement with G.C. Group 13

One World Cannabis Signs Collaboration Agreement with Sheba Academic Medical Center 14

OWC Pharmaceutical Research Enters into Agreement with Sheba Academic Medical Center 15

OWC Pharmaceutical Research Enters into Agreement with GUMI Tel Aviv 16

Licensing Agreements 17

OWC Pharmaceutical Enters into License Agreement with Sheba Academic Medical for Fibromyalgia 17

OWC Pharmaceutical Enters into License Agreement with Sheba Academic Medical for Psoriasis 18

Equity Offering 19

OWC Pharma Raises USD5 Million in Private Placement of Shares 19

OWC Pharma to Raise USD0.3 Million in Private Placement of Shares 20

OWC Pharma Raises USD0.02 Million in Priavte Placement of Shares 21

OWC Pharmaceutical Raises USD0.65 Million in Priavte Placement of Shares 22

OWC Pharmaceutical Research Raises USD1.1 Million in Private Placement of Units 23

OWC Pharmaceutical Research Raises USD0.9 Million in Priavte Placement of Units 24

OWC Pharmaceutical Research Corp-Key Competitors 25

OWC Pharmaceutical Research Corp-Key Employees 26

OWC Pharmaceutical Research Corp-Locations And Subsidiaries 27

Head Office 27

Other Locations & Subsidiaries 27

Recent Developments 28

Corporate Communications 28

Feb 20, 2018: OWC Pharmaceutical Research Appoints Dr. Oron Yacoby Zeevi as its Chief Scientific Officer 28

Jul 25, 2017: OWC Pharmaceutical Research Corp Appoints Dr. Stanley Hirsch as its Active Chairman 29

Jan 27, 2017: OWC Pharmaceutical Research Announces the Nominations of Ms. Miriam Sani, MSc Eng., to its Advisory Board 30

Product News 31

Dec 21, 2017: OWC Pharmaceutical Research Announces Update on its Proprietary Medical Cannabis Sublingual Tablet 31

Other Significant Developments 32

Jul 24, 2018: OWC Pharmaceutical Research letter to shareholders 32

Appendix 33

Methodology 33

About GlobalData 33

Contact Us 33

Disclaimer 33


List Of Figure

List of Figures

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

OWC Pharmaceutical Research Corp, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

OWC Pharmaceutical Research Corp, Deals By Therapy Area, 2012 to YTD 2018 8

OWC Pharmaceutical Research Corp, Medical Devices Deals, 2012 to YTD 2018 9

OWC Pharmaceutical Research Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Kodiak Capital Group to Invest USD0.7 Million in OWC Pharma 11

OWC Pharmaceutical Research Entered into a License Agreement with Emilia Cosmetics 12

One World Cannabis Enters into Agreement with G.C. Group 13

One World Cannabis Signs Collaboration Agreement with Sheba Academic Medical Center 14

OWC Pharmaceutical Research Enters into Agreement with Sheba Academic Medical Center 15

OWC Pharmaceutical Research Enters into Agreement with GUMI Tel Aviv 16

OWC Pharmaceutical Enters into License Agreement with Sheba Academic Medical for Fibromyalgia 17

OWC Pharmaceutical Enters into License Agreement with Sheba Academic Medical for Psoriasis 18

OWC Pharma Raises USD5 Million in Private Placement of Shares 19

OWC Pharma to Raise USD0.3 Million in Private Placement of Shares 20

OWC Pharma Raises USD0.02 Million in Priavte Placement of Shares 21

OWC Pharmaceutical Raises USD0.65 Million in Priavte Placement of Shares 22

OWC Pharmaceutical Research Raises USD1.1 Million in Private Placement of Units 23

OWC Pharmaceutical Research Raises USD0.9 Million in Priavte Placement of Units 24

OWC Pharmaceutical Research Corp, Key Competitors 25

OWC Pharmaceutical Research Corp, Key Employees 26

OWC Pharmaceutical Research Corp, Subsidiaries 27

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

OWC Pharmaceutical Research Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.